NRSN
Neurosense Therapeutics
$2.13
−$0.23 (−9.75%)Oct 29, 2026
Key metrics
The numbers that frame NRSN today
- Market cap
- $3.47M
- ROIC
- 561.5%
- Div yield
- 0%
- 52wk Low
- $2.09
- 52wk High
- $25.40
Growth
Revenue and earnings trend for NRSN
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NRSN
Is Neurosense Therapeutics a good buy?
No. Neurosense Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. We think Neurosense Therapeutics is selling at a very high price.
What is the market capitalization of NRSN?
Neurosense Therapeutics's market capitalization is $3.47M.
What is the 52-week high for NRSN stock?
The 52-week high for Neurosense Therapeutics is $25.40. The current close of $2.13 is 91.6% below that high.
What is the 52-week low for NRSN stock?
The 52-week low for Neurosense Therapeutics is $2.09. The current close of $2.13 is 1.9% above that low.
Does NRSN stock pay dividends?
Neurosense Therapeutics does not currently show a dividend per share in the company data.